Market Tracker

05/05 6:02pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.02
Delayed Data
As of May 05
 -0.28 / -5.28%
Today’s Change
3.10
Today|||52-Week Range
7.84
-33.60%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.30
Today’s open5.31
Day’s range5.01 - 5.39
Volume934,205
Average volume (3 months)891,455
Market cap$369.1M
Dividend yield--
Data as of 3:59pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-983.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio77.7
Price/Sales11.62
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...-0.21-5.75%
DERMDermira Inc-0.26-1.78%
XNPTXenoport Inc+0.01+0.17%
XOMAXOMA Corp-0.10-3.08%
Data as of 3:59pm ET, 05/05/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts